Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-22

FDA Approved: GLEOLAN — Supplemental Application (Medexus Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Gleolan (aminolevulinic acid hydrochloride) submitted by Medexus Pharma, Inc. This action constitutes a supplemental…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gleolan (5-aminolevulinic acid hydrochloride)

Snippet

SUPPL AP for GLEOLAN (AMINOLEVULINIC ACID HYDROCHLORIDE)